Search

Search Constraints

You searched for: Author/Creator Glimelius, B

Search Results

1. 455PDNORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC). (23rd October 2018)

3. O-015Randomised trial of cetuximab every 2 weeks with FOLFIRI or cetuximab with alternating FOLFIRI/FOLFOX in patients with RAS and BRAF wild type metastatic colorectal cancer: Nordic 8 results. (2nd July 2019)

4. O-026Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy. (20th June 2018)

5. O-026Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy. (20th June 2018)

7. Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma. Issue 3 (24th October 2007)